Literature DB >> 20395423

Failure of the Ipsogen MutaScreen kit to detect the JAK2 617V>F mutation in samples with additional rare exon 14 mutations: implications for clinical testing and report of a novel 618C>F mutation in addition to 617V>F.

Ilka Warshawsky, Frank Mularo, Carol Hren, Maureen Jakubowski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20395423     DOI： 10.1182/blood-2009-12-257501

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  4 in total

1.  Detection of the JAK2V617F mutation with the Ipsogen MutaScreen kit: absence of JAK2V617F does not mean absence of myeloproliferative neoplasm.

Authors:  Hélène Peyro-Saint-Paul; Fabienne Hermitte
Journal:  Blood       Date:  2010-09-16       Impact factor: 22.113

Review 2.  Genetic Background of Polycythemia Vera.

Authors:  Mathilde Regimbeau; Romain Mary; François Hermetet; François Girodon
Journal:  Genes (Basel)       Date:  2022-04-02       Impact factor: 4.141

3.  Diagnosis of exon 12-positive polycythemia vera rescued by NGS.

Authors:  Antoine Geay; Bernard Aral; Valentin Bourgeois; Pauline Martin; Fabrice Airaud; Céline Garrec; Stéphane Bézieau; Betty Gardie; François Girodon
Journal:  Clin Case Rep       Date:  2020-03-21

4.  A multiplex snapback primer system for the enrichment and detection of JAK2 V617F and MPL W515L/K mutations in Philadelphia-negative myeloproliferative neoplasms.

Authors:  Zhiyuan Wu; Yunqing Zhang; Xinju Zhang; Xiao Xu; Zhihua Kang; Shibao Li; Chen Zhang; Bing Su; Ming Guan
Journal:  Biomed Res Int       Date:  2014-03-05       Impact factor: 3.411
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.